Cullinan Therapeutics develops targeted therapeutics with a focus on oncology and autoimmune diseases, utilizing a modality-agnostic approach. The company self-described as prioritizing patient benefit and employing external collaboration in its research model.
investor of
competitor of
Metrics
marketPRIVATE
msh_idCOM:CULLINANTHERAPEUTICS
localeus
websitehttps://cullinantherapeutics.com/
source_ref8ba49dea-051c-4e20-88c8-eb214354dfc2
products_or_servicesTargeted therapeutics for oncology and autoimmune indications.
United States